Standout Papers

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity ... 2001 2026 2009 2017 522
  1. Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study (2001)
    David Michelson, Douglas E. Faries et al. PEDIATRICS

Immediate Impact

1 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association
2024 Standout
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
3 intermediate papers

Works of Katherine Kendrick being referenced

Strengthening US Food Policies and Programs to Promote Equity in Nutrition Security: A Policy Statement From the American Heart Association
2022
Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association
2020

Author Peers

Author Last Decade Papers Cites
Katherine Kendrick 132 24 84 484 178 12 811
Herschel R. Lessin 84 15 39 608 208 7 936
Robert Dantona 132 33 157 86 8 859
Sarah H. Turbott 99 11 26 474 152 19 808
MD Jr 469 8 24 114 150 7 939
Renee C. Wachtel 92 25 32 241 49 17 806
Daryl L. Bohac 30 10 27 456 209 18 766
Sarah J. Blondell 165 6 108 236 44 11 749
Bennett A. Shaywitz 112 19 9 176 213 26 881
Steve Salloway 55 9 30 325 182 16 805
Elizabeth R. Disney 118 20 479 67 8 879

All Works

Loading papers...

Rankless by CCL
2026